Logo

MDL to Provide Discovery Informatics Systems to Nikem Research

Dec 03, 2001

NEW YORK, Dec. 3—MDL Information Systems announced Monday that it will provide software and informatics systems for NiKem Research Srl, the medicinal chemistry spinoff of GlaxoSmithKline’s former R&D center in Milan, Italy.

NiKem will use MDL’s applications in all stages of drug discovery research, including reagent selection, assay design and biological data capture, storage and analysis, chemical data searching, and chemical registration.

NiKem Research, which was formed in August 2001 by former SmithKline Beecham scientists, supplies services and products to the pharmaceutical industry. It is currently focused on lead optimization in pre-clinical drug development.

GlaxoSmithKline holds a minority equity stake in the company, and has a two-year contract with NiKem for lead optimization in treatments for neurology and respiratory diseases.

MDL Information Systems, based in San Leandro, Calif., is a subsidiary of Elsevier Science.

Breaking News
The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.